Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis
{{output}}
Background: Granulomatosis with polyangiitis (GPA) is a systemic autoimmune disease characterized by small and medium vessel vasculitis. The use of biological therapies such as rituximab and infliximab has improved the treatment ... ...
